Gary Patou Net Worth & Insider Trades

Gary Patou - Director, Xenon Pharmaceuticals Inc

As of November 28, 2022

What is Gary Patou's Net Worth?

The current estimated net worth of Xenon Pharmaceuticals Inc's Director, Gary Patou, is estimated to be about $10.99M . Gary Patou owns about 36,073 units of Xenon Pharmaceuticals Inc common stock. In the last 8 years at Xenon Pharmaceuticals Inc, Gary Patou has sold an estimated value of $216.88K worth.

What is Gary Patou's Past Insider Trading?

Gary Patou's largest purchase order was 7,500 units , worth over $20.84K on August 14, 2017. Gary Patou's largest sale order was 4,114 units , worth over $142.12K on November 28, 2022. In total, Gary Patou has made about 20 transactions over 8 years of their time at Xenon Pharmaceuticals Inc. Gary Patou usually trades in June, with the busiest year in 2017, 2015 and 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Xenon Pharmaceuticals Inc's Past Insider Trades?

Xenon Pharmaceuticals Inc's most recent insider trade came on November 28, 2022 by Gary Patou who sold 4,114 units worth $142.12K . In the last 7 years, insiders at Xenon Pharmaceuticals Inc have sold an estimated value of $20.43M and bought an estimated value of $6.27M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Simon Pimstone, Director,  Michael Tarnow, Director,  and Gary Patou, Director .

Xenon Pharmaceuticals Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1